C
Cindy A. Leissinger
Researcher at Tulane University
Publications - 124
Citations - 5722
Cindy A. Leissinger is an academic researcher from Tulane University. The author has contributed to research in topics: Haemophilia & Haemophilia A. The author has an hindex of 31, co-authored 121 publications receiving 5113 citations. Previous affiliations of Cindy A. Leissinger include LSU Health Sciences Center New Orleans & University Medical Center New Orleans.
Papers
More filters
Journal ArticleDOI
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Marilyn J. Manco-Johnson,Marilyn J. Manco-Johnson,Thomas C. Abshire,Amy D. Shapiro,Brenda Riske,Michele R. Hacker,Ray F. Kilcoyne,J. David Ingram,M L Manco-Johnson,Sharon Funk,Linda J. Jacobson,Leonard A. Valentino,W. Keith Hoots,George R. Buchanan,Donna DiMichele,Michael Recht,Deborah L Brown,Cindy A. Leissinger,Shirley Bleak,Alan R. Cohen,Prasad Mathew,Alison Matsunaga,Desiree Medeiros,Diane J. Nugent,Gregory Thomas,Alexis A. Thompson,Kevin McRedmond,J. Michael Soucie,Harlan Austin,Bruce L. Evatt +29 more
TL;DR: Prophylaxis with recombinant factor VIII can prevent joint damage and decrease the frequency of joint and other hemorrhages in young boys with severe hemophilia A.
Journal ArticleDOI
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Sherrill J. Slichter,Richard M. Kaufman,Susan F. Assmann,Jeffrey McCullough,Darrell J. Triulzi,Ronald G. Strauss,Terry Gernsheimer,Paul M. Ness,Mark E. Brecher,Cassandra D. Josephson,Barbara A. Konkle,Robert D. Woodson,Thomas L. Ortel,Christopher D. Hillyer,Donna Skerrett,Keith R. McCrae,Steven R. Sloan,Lynne Uhl,James N. George,Victor M. Aquino,Catherine S. Manno,Janice G. McFarland,John R. Hess,Cindy A. Leissinger,Suzanne Granger +24 more
TL;DR: Low doses of platelets administered as a prophylactic transfusion led to a decreased number of platelet transfused per patient but an increased number of transfusions given.
Journal ArticleDOI
Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.
TL;DR: A review of the published literature over the last 30 years found that PCCs offer a rapid and specific method for replacing vitamin K‐dependent clotting factors and restoring normal hemostasis in the context of over‐coagulation.
Journal ArticleDOI
Acquired hemophilia A: Updated review of evidence and treatment guidance.
Rebecca Kruse-Jarres,Christine L. Kempton,Francesco Baudo,Peter William Collins,Paul Knoebl,Cindy A. Leissinger,Andreas Tiede,Craig M. Kessler +7 more
TL;DR: Acquired hemophilia A is a rare disease resulting from autoantibodies against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and severe.
Journal ArticleDOI
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors.
Cindy A. Leissinger,Alessandro Gringeri,Bülent Antmen,Erik Berntorp,Chiara Biasoli,Shannon L. Carpenter,Paolo Cortesi,Hyejin Jo,Kaan Kavakli,Riitta Lassila,Massimo Morfini,Claude Negrier,Angiola Rocino,Wolfgang Schramm,Margit Serban,Marusia Valentina Uscatescu,Jerzy Windyga,Bulent Zulfikar,Lorenzo G. Mantovani +18 more
TL;DR: AICC prophylaxis at the dosage evaluated significantly and safely decreased the frequency of joint and other bleeding events in patients with severe hemophilia A and factor VIII inhibitors.